The expression of prolactin receptors in benign breast tumors is not associated with serum prolactin levelVisa övriga samt affilieringar
2021 (Engelska)Ingår i: Journal of Clinical Medicine, E-ISSN 2077-0383, Vol. 10, nr 24, artikel-id 5866Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
The role of prolactin (PRL) and its receptors in the initiation and development of benign breast tumors (BBT) has not been sufficiently studied. An imbalance in the system of hormone homeostasis is crucial in the development of BBT. In particular, an association between elevated prolactin levels and the development of BBT has been reported. Our study showed no significant differences between PRL receptor (PRL-R) expression in BBT tissue under normal and elevated serum PRL levels. There was also no significant correlation between age, PRL-R expression in BBT tissue, intact tissue, and PRL level in the serum. There was a strong significant correlation (p < 0.01; r = 0.92) between PRL-R expression in BBT samples and intact breast tissue, which did not depend on the serum PRL level. There was also no significant difference in the expression of the proliferative marker Ki-67 in BBT tissues from women with normal and elevated levels of serum PRL (p > 0.05). No signs of PRL and its receptors were detected in the BBT cystic fluid women with elevated serum PRL levels. In summary, our prospective study showed that the expression of PRL-R in the tissue of BBT and physiological breast tissue does not depend on the level of serum PRL.
Ort, förlag, år, upplaga, sidor
MDPI, 2021. Vol. 10, nr 24, artikel-id 5866
Nyckelord [en]
Benign breast tumors, Prolactin, Prolactin receptors
Nationell ämneskategori
Fysiologi och anatomi
Identifikatorer
URN: urn:nbn:se:umu:diva-190813DOI: 10.3390/jcm10245866ISI: 000737981100001Scopus ID: 2-s2.0-85121030614OAI: oai:DiVA.org:umu-190813DiVA, id: diva2:1623451
2021-12-292021-12-292025-02-10Bibliografiskt granskad